FTC sues key pharmacy reward supervisors about insulin costs The agency introduced motion in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of lifestyle-saving insulin drugs. UnitedHealth sues CMS over Medicare Advantage star scores A few designs owned https://daveshotchickennutrition15049.blogrelation.com/36754124/not-known-facts-about-healthcare-news